PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Ck-beta-11 4 Target Disease Breast Cancer 173,695 1 0.00 -0.87 0.25 0.59
CCL4 5,638 Target Target CCBL1 4 1 0.01 -0.87 0.25 0.66
CCL2 3,560 Target Target CCL1 220 55 0.06 -0.86 0.25 0.76
Ck-beta-11 4 Target Target CD34 24,598 1 0.00 -0.87 0.25 0.63
ADRBK2 8 Target Disease Cancer 1,053,491 2 0.00 -0.87 0.25 0.55
CD62L/L-Selectin 8 Target Disease Cancer 1,053,491 2 0.00 -0.87 0.25 0.55
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Target Collagen 138,882 1 0.00 -0.87 0.25 0.59
Xaa-Pro Dipeptidase 4 Target Disease Diabetic Nephropathy 12,496 1 0.00 -0.87 0.25 0.64
Xaa-Pro Dipeptidase 4 Target Target EGF 27,487 1 0.00 -0.87 0.25 0.62
Estrogen Receptor Beta 1,924 Target Target Egl Nine Homolog 1 4 1 0.01 -0.87 0.25 0.69
Ck-beta-11 4 Target Target Exodus-2 27 1 0.10 -0.85 0.25 0.84
Ck-beta-11 4 Target Target Exodus-3 8 1 0.18 -0.81 0.25 0.89
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Disease Inflammation 252,734 1 0.00 -0.87 0.25 0.58
Glutathione S-Transferase Mu 2 8 Target Disease Inflammation 252,734 2 0.00 -0.87 0.25 0.58
Prostaglandin Reductase 1 8 Target Disease Inflammation 252,734 2 0.00 -0.87 0.25 0.58
Kappa-Type Opioid Receptor 4 Target Target Sphingosine 1-Phosphate Receptor 1 150 1 0.04 -0.86 0.25 0.77
Epidermal Growth Factor Receptor 24,772 Target Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.63
Epidermal Growth Factor Receptor 24,772 Target Target ERBB3 1,154 289 0.05 -0.86 0.25 0.72
CXCL9 1,016 Target Disease Inflammation 252,734 256 0.02 -0.86 0.25 0.63
CD4 112,219 Target Target CD137 474 120 0.02 -0.86 0.25 0.64
CCL3 1,427 Target Disease Inflammation 252,734 365 0.02 -0.86 0.26 0.63
CCL2 3,560 Target Target CXCL2 750 192 0.12 -0.84 0.26 0.80
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Glioblastoma 17,933 10 0.01 -0.86 0.26 0.66
CD148 74 Target Target DEP-1 88 19 0.24 -0.76 0.26 0.90
Exodus-2 27 Target Target CCL21 808 7 0.05 -0.86 0.26 0.76
Calmodulin 25,240 Target Target DAPK2 27 7 0.01 -0.86 0.26 0.65
ELC 355 Target Target Exodus-2 27 7 0.07 -0.85 0.26 0.79
CD146 729 Target Target CD34 24,598 190 0.04 -0.86 0.26 0.71
BMP-6 386 Target Target BMP-4 1,255 101 0.15 -0.82 0.26 0.83
CCL2 3,560 Target Target CXCL3 145 38 0.05 -0.85 0.26 0.75
DDR2 194 Target Disease Cancer 1,053,491 51 0.00 -0.86 0.26 0.57
AMAC-1 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
Eotaxin-2/CCL24 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
Mu Opioid Receptor 4,576 Target Target Mu-Type Opioid Receptor 19 5 0.02 -0.86 0.26 0.69
CXCL10 2,386 Target Target CCL8 197 52 0.08 -0.85 0.26 0.77
ACRP30 102 Target Disease Diabetes 332,602 27 0.00 -0.86 0.26 0.59
BMX 185 Target Target BTK 1,263 49 0.10 -0.84 0.26 0.80
APOE 12,771 Target Disease Cholesterol 182,390 3,396 0.07 -0.85 0.27 0.69
CD4 112,219 Target Target 4-1BB Ligand 135 36 0.01 -0.86 0.27 0.63
Lanosterol 14 Alpha-Demethylase 101 Target Disease Cholesterol 182,390 27 0.01 -0.86 0.27 0.61
CA125 Antigen 78 Target Disease Carcinoma 433,099 21 0.00 -0.85 0.27 0.59
Dihydropteroate Synthase 408 Target Disease Malaria 56,215 110 0.02 -0.85 0.27 0.67
CD22 1,591 Target Disease Leukemia 162,805 430 0.03 -0.85 0.27 0.65
ADSF 11 Target Target Adiponectin 11,994 3 0.01 -0.85 0.27 0.66
Epidermal Growth Factor Receptor 24,772 Target Target Epiregulin 291 80 0.03 -0.85 0.27 0.69
CD4 112,219 Target Disease Infection 766,637 30,996 0.11 -0.83 0.28 0.68
Angiotensin Converting Enzyme 31,674 Target Target Aldosterone Receptor 528 146 0.04 -0.85 0.28 0.69
Des (1-3) IGF-I 191 Target Target Des (1-6) IGF-II 18 5 0.09 -0.84 0.28 0.81
5-Hydroxytryptamine 2b Receptor 18 Target Disease Heart Disease 118,291 5 0.00 -0.85 0.28 0.61
Phosphodiesterase 4b 54 Target Disease Schizophrenia 77,034 15 0.01 -0.85 0.28 0.63
Aldosterone Receptor 528 Target Target Renin 43,456 147 0.03 -0.85 0.28 0.68
CCL5 2,002 Target Disease Inflammation 252,734 565 0.03 -0.85 0.28 0.64
Estrogen Receptor Beta 1,924 Target Disease Cancer 1,053,491 543 0.01 -0.85 0.28 0.59
AACT 109 Target Target Alpha-1 AntiChymotrypsin 1,460 31 0.08 -0.84 0.28 0.78
Androgen Receptor 12,918 Target Drug Avodart (Dutasteride)- FDA 7 2 0.01 -0.85 0.29 0.65
CD31/PECAM1 7 Target Target CD34 24,598 2 0.00 -0.85 0.29 0.64
Endostatin 1,599 Target Target Angiostatin K1-3 17 5 0.03 -0.84 0.29 0.73
Epidermal Growth Factor Receptor 24,772 Target Target beta-Cellulin 17 5 0.01 -0.84 0.29 0.65
Epidermal Growth Factor Receptor 24,772 Target Target Epigen 27 8 0.01 -0.84 0.30 0.65
Epigen 27 Target Target Epiregulin 291 8 0.09 -0.83 0.30 0.81
CCN5 57 Target Target CYR61 539 17 0.10 -0.82 0.30 0.81
Neuropeptide S Receptor 77 Target Disease Asthma 109,610 23 0.01 -0.84 0.30 0.62
CCL8 197 Target Disease Inflammation 252,734 59 0.01 -0.84 0.30 0.61
BMP-7 1,112 Target Target BMP-2 3,889 338 0.16 -0.80 0.30 0.82
CCL7 274 Target Target CCL8 197 60 0.26 -0.74 0.30 0.90
Eotaxin 2,457 Target Disease Asthma 109,610 749 0.05 -0.83 0.30 0.68
AURKC 26 Target Disease Infertility 35,448 8 0.01 -0.83 0.31 0.64
CCL7 274 Target Disease Inflammation 252,734 85 0.01 -0.83 0.31 0.62
CCL2 3,560 Target Disease Inflammation 252,734 1,105 0.04 -0.83 0.31 0.65
BD2 76 Target Target BD3 32 10 0.20 -0.77 0.31 0.88
EPHB2 385 Target Target EPHB1 137 43 0.19 -0.78 0.31 0.86
CD4 112,219 Target Target CD154 1,512 477 0.04 -0.83 0.32 0.67
CXCL3 145 Target Disease Inflammation 252,734 46 0.01 -0.83 0.32 0.61
BMP-4 1,255 Target Target BMP-2 3,889 399 0.18 -0.78 0.32 0.83
Androgen Receptor 12,918 Target Disease Prostate Cancer 71,064 4,112 0.14 -0.80 0.32 0.76
CCL2 3,560 Target Target CXCL10/IP-10 114 37 0.06 -0.82 0.32 0.75
CXCL10/IP-10 114 Target Target CXCL9 1,016 37 0.11 -0.81 0.32 0.81
Vanilloid Receptor 1 404 Target Disease Pain 409,851 132 0.01 -0.82 0.33 0.61
ApoE2 517 Target Disease Cholesterol 182,390 170 0.02 -0.82 0.33 0.64
CD4 112,219 Target Drug Acyclovir for Injection (Zovirax Injection)- FDA 3 1 0.00 -0.82 0.33 0.60
Glucocorticoid Receptor 10,306 Target Drug Aminoglutethimide (Cytadren)- FDA 3 1 0.01 -0.82 0.33 0.65
Angiotensin Converting Enzyme 31,674 Target Drug Atacand (Candesartan Cilexetil)- FDA 3 1 0.00 -0.82 0.33 0.63
BMP-2B 18 Target Target BMP-4 1,255 6 0.04 -0.81 0.33 0.74
Mu Opioid Receptor 4,576 Target Target CTAP-3 6 2 0.01 -0.82 0.33 0.68
CCL3 1,427 Target Target CXCL4/PF4 9 3 0.03 -0.82 0.33 0.72
CXCL11 526 Target Target CXCL4/PF4 9 3 0.04 -0.81 0.33 0.76
Dipeptidyl Peptidase 3 3 Target Disease Cancer 1,053,491 1 0.00 -0.82 0.33 0.56
Alk Tyrosine Kinase Receptor 3 Target Disease Cancer 1,053,491 1 0.00 -0.82 0.33 0.56
Heat Shock Protein Hsp 90-Beta 3 Target Disease Cancer 1,053,491 1 0.00 -0.82 0.33 0.56
BMP-2B 18 Target Target Collagen 138,882 6 0.00 -0.82 0.33 0.61
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Epilepsy 71,172 3 0.00 -0.82 0.33 0.62
Heat Shock Protein Hsp 90-Beta 3 Target Disease Gastritis 17,713 1 0.00 -0.82 0.33 0.64
Enovin 3 Target Disease Inflammation 252,734 1 0.00 -0.82 0.33 0.58
Tubulin Beta-1 Chain 3 Target Target Inosine-5'-Monophosphate Dehydrogenase 261 1 0.04 -0.81 0.33 0.76
Alk Tyrosine Kinase Receptor 3 Target Disease Lung Cancer 91,416 1 0.00 -0.82 0.33 0.60
Dipeptidyl Peptidase 3 3 Target Disease Malaria 56,215 1 0.00 -0.82 0.33 0.61
ACRP30 102 Target Disease Obesity 138,233 34 0.01 -0.82 0.33 0.62
Microsomal Glutathione S-Transferase 2 6 Target Disease Psoriasis 26,882 2 0.00 -0.82 0.33 0.64
Calmodulin 25,240 Target Target Tubulin Beta-1 Chain 3 1 0.00 -0.82 0.33 0.63
CCL5 2,002 Target Target CCL2 3,560 673 0.25 -0.73 0.34 0.87